RxDoctor Payments Data

Stephanie Ackner, MD

Psychiatry · Dayton, OHNPI 1285734566

Payments from drug & device makers

$1,330in general payments, 2019–2025

Across 70 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$286
  • Otsuka America Pharmaceutical, Inc.$195
  • E.r. Squibb & Sons, L.L.C.$185
  • Vanda Pharmaceuticals Inc.$168
  • Alkermes, Inc.$119
  • Neurocrine Biosciences, Inc.$100
  • plus $277 from 8 others

What the payments were for

  • Food & beverage$1,21992%
  • Education$1118%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,330 in reported general payments places this provider in the 75th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$6,804
Medicare patients
23
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate14$48,145
Abilify MaintenaAripiprazole17$43,762
VraylarCariprazine Hcl25$35,580
TrintellixVortioxetine Hydrobromide53$28,063
RexultiBrexpiprazole14$18,606
Lurasidone Hcl12$14,549
Paliperidone ErPaliperidone64$12,007
Vilazodone Hcl51$4,740
Atomoxetine Hcl51$3,664
Quetiapine Fumarate ErQuetiapine Fumarate30$3,152
Chlorpromazine Hcl11$2,803
Clozapine68$2,473
Duloxetine Hcl120$1,974
Bupropion XlBupropion Hcl130$1,806
Olanzapine66$1,432

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$195$62,36831 claims
Johnson & JohnsonInvega Sustenna$100$48,14514 claims
AbbVieVraylar$15$35,58025 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$19$28,06353 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →